Full name: Jieruo Gu
Current country: China
Membership level: Full
Type of membership: Member
Number of publications: 30
The pattern and trends of disease burden due to low bone mineral density from 1990 to 2019 in China: findings from the Global Burden of Disease Study 2019 (2022)
https://pubmed.ncbi.nlm.nih.gov/35247103/
Ataxia-televangelist mutated (ATM)/ ATR serine/threonine kinase (ATR)-mediated RAD51 recombinase (RAD51) promotes osteogenic differentiation and inhibits osteoclastogenesis in osteoporosis (2022)
https://pubmed.ncbi.nlm.nih.gov/35176943/
Quantification of Fat Metaplasia in the Sacroiliac Joints of Patients With Axial Spondyloarthritis by Chemical Shift-Encoded MRI: A Diagnostic Trial (2022)
https://pubmed.ncbi.nlm.nih.gov/35116037/
Integrative blood-derived epigenetic and transcriptomic analysis reveals the potential regulatory role of DNA methylation in ankylosing spondylitis (2022)
https://pubmed.ncbi.nlm.nih.gov/34986893/
Distribution of Acute and Chronic Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis (2022)
https://pubmed.ncbi.nlm.nih.gov/35018115/
Efficacy and safety of Fengshi Gutong Capsule in patients with active ankylosing spondylitis: A 4-week randomized controlled, double-blinded, double-dummy trial (2022)
https://pubmed.ncbi.nlm.nih.gov/34634368/
Dynamics of Adaptive Immune Cell and NK Cell Subsets in Patients With Ankylosing Spondylitis After IL-17A Inhibition by Secukinumab (2022)
https://pubmed.ncbi.nlm.nih.gov/34721027/
Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/34539629/
Active Inflammatory and Chronic Structural Damages of Sacroiliac Joint in Patients With Radiographic Axial Spondyloarthritis and Non-Radiographic Axial Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34386008/
Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis (2021)
https://pubmed.ncbi.nlm.nih.gov/34295337/
The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study (2021)
https://pubmed.ncbi.nlm.nih.gov/33188428/
Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy (2021)
https://pubmed.ncbi.nlm.nih.gov/33679777/
Comorbidities and factors influencing frequent gout attacks in patients with gout: a cross-sectional study (2021)
https://pubmed.ncbi.nlm.nih.gov/33538925/
Pattern and trend of five major musculoskeletal disorders in China from 1990 to 2017: findings from the Global Burden of Disease Study 2017 (2021)
https://pubmed.ncbi.nlm.nih.gov/33536019/
Age-Specific Imbalance of Circulating Tfh Cell Subsets and Its Association With Gout-Targeted Kidney Impairment (2021)
https://pubmed.ncbi.nlm.nih.gov/33505406/
The Clinical Characteristics of Other HLA-B Types in Chinese Ankylosing Spondylitis Patients (2021)
https://pubmed.ncbi.nlm.nih.gov/33490092/
Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases (vol 39, pg 2425, 2020) (2021)
https://pubmed.ncbi.nlm.nih.gov/32103375/
Cost of Illness, Quality of Life, and Work Outcomes in Active Ankylosing Spondylitis Patients Treated With Adalimumab in China (2021)
https://pubmed.ncbi.nlm.nih.gov/33330342/
Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases (2020)
https://pubmed.ncbi.nlm.nih.gov/33047841/
Identification of the urine and serum metabolomics signature of gout (2020)
https://pubmed.ncbi.nlm.nih.gov/32134107/
Comparison of efficacy and safety of urate-lowering therapies for hyperuricemic patients with gout: a meta-analysis of randomized, controlled trials (2020)
https://pubmed.ncbi.nlm.nih.gov/32654080/
TNF-alpha inhibitor therapy can improve the immune imbalance of CD4+T cells and negative regulatory cells but not CD8+T cells in ankylosing spondylitis (2020)
https://pubmed.ncbi.nlm.nih.gov/32560733/
Pain- and Fatigue-Related Functional and Structural Changes in Ankylosing Spondylitis: An fRMI Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32500077/
Analysis of 47 Non-MHC Ankylosing Spondylitis Susceptibility Loci Regarding Associated Variants across Whites and Han Chinese0 (2020)
https://pubmed.ncbi.nlm.nih.gov/31523044/
Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study (2020)
https://pubmed.ncbi.nlm.nih.gov/32210816/
Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis (2019)
https://pubmed.ncbi.nlm.nih.gov/31807552/
Spondyloarthritis Patients Suffer Increased Risk of Renal Complications Compared With General Population: A Retrospective Observational Study (2019)
https://pubmed.ncbi.nlm.nih.gov/31620002/
Efficacy and safety of loxoprofen hydrogel patch versus loxoprofen tablet in patients with ankylosing spondylitis: A 4-week randomized, open-label study (vol 10, pg 331, 2019) (2019)
https://pubmed.ncbi.nlm.nih.gov/31139408/
Aberrant expression of microRNAs in peripheral blood mononuclear cells as candidate biomarkers in patients with axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30990253/
Prevalence of comorbidities and evaluation of screening in Chinese patients with spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/29204757/